Cartagena A, Prasad AN, Rupar CA, Strong M, Tuchman M, Ah Mew N, Prasad C
Fras, J.P
An analysis of the SEER database demonstrates that DPP-4 inhibitors may improve survival outcomes in patients with colorectal and lung cancer [19]
7 MDS-related TOD including macrovascular diseases and microvascular complications, such as chronic kidney disease (CKD), retinopathy, neuropathy, along with diabetic foot ulcerations (DFU), are responsible for much of the burden associated with diabetes
Improved microbiota composition may further enhance semaglutides efficacy and tolerability by lowering gut-derived inflammation, thus potentially optimising GLP-1 analogue action (Fig